Cargando…

Emerging Therapies in Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is a rare autoimmune disorder caused by peripheral platelet destruction and inappropriate bone marrow production. The management of ITP is based on the utilization of steroids, intravenous immunoglobulins, rituximab, thrombopoietin receptor agonists (TPO-RAs), immunosup...

Descripción completa

Detalles Bibliográficos
Autores principales:	Audia, Sylvain, Bonnotte, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958340/ https://www.ncbi.nlm.nih.gov/pubmed/33801294 http://dx.doi.org/10.3390/jcm10051004

Ejemplares similares

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments
por: Audia, Sylvain, et al.
Publicado: (2021)

Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients
por: Estève, Clémentine, et al.
Publicado: (2017)

Evans’ Syndrome: From Diagnosis to Treatment
por: Audia, Sylvain, et al.
Publicado: (2020)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
por: Rogier, Thomas, et al.
Publicado: (2020)

T Lymphocyte Plasticity in Autoimmunity and Cancer
por: Janikashvili, Nona, et al.
Publicado: (2015)

Impact of BRAF(V600E) mutation on aggressiveness and outcomes in adult clonal histiocytosis
por: Razanamahery, Jerome, et al.
Publicado: (2023)

Emerging Concepts in Immune Thrombocytopenia
por: Swinkels, Maurice, et al.
Publicado: (2018)

Assessment and Management of Immune Thrombocytopenia (ITP) in the Emergency Department: Current Perspectives
por: Zitek, Tony, et al.
Publicado: (2022)

Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.
por: Razanamahery, Jerome, et al.
Publicado: (2021)

Biomarkers for immune thrombocytopenia
por: Yu, Lingjia, et al.
Publicado: (2015)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019)

T cell immune abnormalities in immune thrombocytopenia
por: Ji, Xuebin, et al.
Publicado: (2014)

T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients
por: Heitz, Jade, et al.
Publicado: (2022)

Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAF(V600E) -Mutated Erdheim–Chester Disease: A Case Report
por: Razanamahery, Jérôme, et al.
Publicado: (2022)

T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients
por: Samson, Maxime, et al.
Publicado: (2022)

Covid-19 and Children with Immune Thrombocytopenia: Emerging Issues
por: Lassandro, Giuseppe, et al.
Publicado: (2020)

Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study
por: Guillet, Stéphanie, et al.
Publicado: (2023)

Current Management of Primary Immune Thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2015)

Advances in Diagnosis and Treatments for Immune Thrombocytopenia
por: Nomura, Shosaku
Publicado: (2016)

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
por: Datta, Payel, et al.
Publicado: (2021)

Immune thrombocytopenia
Publicado: (2011)

Romiplostim for the Emergency Management of Severe Immune Thrombocytopenia with Intracerebral Hemorrhage
por: Gellens, Romain, et al.
Publicado: (2018)

Treatment of drug-induced immune thrombocytopenias
por: Marini, Irene, et al.
Publicado: (2022)

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
por: Tomasello, Riccardo, et al.
Publicado: (2021)

Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia
por: Sun, Siyu, et al.
Publicado: (2021)

A Review on Secondary Immune Thrombocytopenia in Malaysia
por: Zahidin, Muhamad Aidil, et al.
Publicado: (2021)

Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy
por: Sun, Rui-jie, et al.
Publicado: (2019)

Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
por: Zufferey, Anne, et al.
Publicado: (2017)

Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
por: Vayne, Caroline, et al.
Publicado: (2020)

The role of romiplostim for pediatric patients with immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Recent advances in the mechanisms and treatment of immune thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2022)

The Extensive Regulation of MicroRNA in Immune Thrombocytopenia
por: Zhao, Yuerong, et al.
Publicado: (2022)

Helicobacter pylori Infection and Chronic Immune Thrombocytopenia
por: Takeuchi, Hiroaki, et al.
Publicado: (2022)

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
por: Crickx, Etienne, et al.
Publicado: (2023)

Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia
por: Allegra, Alessandro, et al.
Publicado: (2023)

Efgartigimod alfa for the treatment of primary immune thrombocytopenia
por: Broome, Catherine
Publicado: (2023)

Transitioning patients with immune thrombocytopenia to second‐line therapy: Challenges and best practices
por: Cuker, Adam
Publicado: (2018)

Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
por: Janikashvili, Nona, et al.
Publicado: (2021)

Venous thromboembolic events during warm autoimmune hemolytic anemia
por: Audia, Sylvain, et al.
Publicado: (2018)

Specific blood monocyte distribution in histiocytoses correlates with vascular involvement and disease activity
por: Razanamahery, Jerome, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hkqfgblk8oi6ajtv59u05s8jc6